Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41M
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
5.26M
-
Shares change
-
+123K
-
Total reported value, excl. options
-
$15.4M
-
Value change
-
+$424K
-
Put/Call ratio
-
0.33
-
Number of buys
-
21
-
Number of sells
-
-24
-
Price
-
$2.92
Significant Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q1 2024
66 filings reported holding ORMP - ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share as of Q1 2024.
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.26M shares
of 41M outstanding shares and own 12.83% of the company stock.
Largest 10 shareholders include Murchinson Ltd. (1.38M shares), BML Capital Management, LLC (844K shares), BOOTHBAY FUND MANAGEMENT, LLC (690K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (344K shares), Rathbones Group Plc (290K shares), BANK OF AMERICA CORP /DE/ (287K shares), TWO SIGMA ADVISERS, LP (264K shares), TWO SIGMA INVESTMENTS, LP (134K shares), RENAISSANCE TECHNOLOGIES LLC (122K shares), and BlackRock Inc. (89.3K shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.